健康元

1 1
2 2
1 1
关于我们

ABOUT US 

Joincare (Joincare Pharmaceutical Group Industry Co., Ltd) was founded in 1992, and the company located the headquarter in Shenzhen Special Economic Zone. With years of steady operation and fast development, Joincare has become a pluralistic, comprehensive company. The integrative business of Joincare includes invention, manufacture, selling and service of healthcare product. Among over 20 subsidiary companies, Joincare and Livzon have been listed on the market. At the end of 2019, around 13000 employees were working for the company, and the total asset of the company accounted for 25.438 billion yuan, of which the operating income reached 11.980 billion yuan.

More

NEWS

31
2020/08

Exploring the Blue Ocean Market of Inhalation Industry!Two Major Products Developed by Joincare Were Permitted to Produce

In the evening of 24th, Aug., Joincare Pharmaceutical Group Industry Co., Ltd (Joincare) has released the public notification that the company gained the ‘Drug Production License’ (DPL). Until now, the two major combination medicinal products developed by Joincare, Compound Ipratropium Bromide Solution for Inhalation and Levosalbutamol Hydrochloride Nebuliser Solution, have begun to be manufactured.
29
2019/05

One inhalation solution drug of Joincare obtained registration approval

Shanghai Securities News and cnstock news Joincare announced on the evening of April 9 that the Compound Ipratropium Bromide Solution for Inhalation developed by it has recently received the Drug Re
23
2020/03

Abating fever caused by NCV with a half dose of medicine: TCM saved my life!

The NCV outbreaking recently is a serious public health emergency. Its fastest, broadest contagion has brought about the more difficulty in its prevention than ever since the foundation of China.
23
2020/03

Zheng Yuan Dan,Seasonal Flu Prevention:Ginseng antiphlogistic powder,a exclusive health strategy for you

TraditionalChineseMedicineplaysabigroleinthepandemicbattle AsthesituationofbattlingwithCOVID-19inChinahasgraduallygottenbetter,Chinaturnstooffersupporttoothercountriesinneedafterreceivingfriendlyassis
23
2020/03

Time-honored Confidence in Traditional Medicine: Ginseng Antiphlogistic Capsule Has an Outstanding Effect on Curing Plague

According to Traditional Chinese Medicine Therapeutic Schedule for Novel Coronavirus Pneumonia (2nd Trial Edition) released on 2nd, Feb., doctors are recommended to apply ginseng antiphlogistic powder (GAP) into therapy if the patients show wind-cold on appearance, lack of Qi and stagnation of dampness-evil.
20
2020/03

Donated 22 million yuan to fight against the COVID-19 outbreak, Joincare and Livzon Group practiced social responsibility

Summary: On January 28, in order to fight against the pneumonia outbreak caused by the novel coronavirus, Joincare Pharmaceutical Group Co., Ltd. (hereinafter referred to as the "Joincare Group"), and
More

OUR BUSINESS

SEARCH FOR THE PRODUCTS YOU NEED

Search
投资者关系

Corporate Social Responsibility

More
工作机会

Investor Relations

More
企业社会责任

Job Opportunities

More

Quick Navigation

Service Hotline

Service

Hotline

Copyright © Joincare Pharmaceutical Group Industry Co., Ltd. All Rights Reserved.  Powered by:www.300.cn Zhuhai  粤ICP备14024104号